Please login to the form below

Not currently logged in
Email:
Password:

Joint ownership for Indigenus network

Thirteen agencies pool resources to provide global creative services to healthcare clients

The 13 independent agencies in the Indigenus network have formally pooled their resources to provide a global creative service to healthcare clients by becoming a limited liability company (LLC).

By unifying under a joint-ownership structure, the founding partners believe that they can offer clients delivery of inspired creative and strategic thinking.

With a network spanning both major and emerging global markets, Indigenus helps pharmaceutical and healthcare companies in the fields of multichannel global branding, advertising, medical education and medical communications. It has local agency teams that work in partnership with global brand teams.

"Indigenus has always brought together the best entrepreneurial brains in the business," said Rico Viray, founding partner of Indigenus and The CementBloc in New York, US. "Clients know they can get consistently superior thinking from independent creative agencies, and we join forces to allow clients to tap into this kind of service on a global basis."

The 13 agencies are: The CementBloc (US), PAN Advertising (UK), Umbilical (Spain), Strategik & Numerik (France), Serviceplan (Germany), thenewway (Italy), Marketing Latino (Mexico), Sorento Health (India), Graphinn (Turkey), me&lewis (Canada), Lindh & Partners (Sweden), PharMa International (Japan) and Micó Publicidad (Argentina).

The Indigenus Transcreation Center (ITC), based in New York, US, caters for the emerging markets via its culturally sensitive adaptation and translation services to manage cost-efficient rollouts across local markets. It has a 200-country virtual network.

Indigenus was founded in 2004 to provide an alternative to traditional advertising agency conglomerates. In 2011, Indigenus will continue to expand its network and has potential agency partners in Brazil, Australia, China, and Russia.

14th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics